Cargando…
Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
Autores principales: | Kow, Chia Siang, Ramachandram, Dinesh Sangarran, Hasan, Syed Shahzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296499/ https://www.ncbi.nlm.nih.gov/pubmed/35933189 http://dx.doi.org/10.1016/j.medcli.2022.05.016 |
Ejemplares similares
-
Direct oral anticoagulants (DOAC) for patients with atrial fibrillation during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022) -
Statin use in patients with diabetes amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2022) -
Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021) -
Colchicine for COVID-19: Hype or hope?
por: Kow, Chia Siang, et al.
Publicado: (2022) -
Insulin therapy in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)